UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Eisai’s Aricept dominates dementia treatment market
Eisai’s Aricept has comfortably secured the No. 1 place in the local dement...
by So Jae-hyeon
|
2018-06-29 15:24
라인
Botulinum toxin makers compete to expand indications
Local developers of botulinum toxins are increasingly competing to expand t...
by So Jae-hyeon
|
2018-06-29 14:07
라인
GC, SK Chemical vaccines win export deals
Korean vaccine manufacturers led by GC and SK Chemical are winning more dea...
by So Jae-hyeon
|
2018-06-25 12:13
라인
Why was Il-yang out from innovative pharmaceutical firms list?
Il-yang Pharmaceutical, HanAll Biopharma, and Bioneer have failed to renew ...
by So Jae-hyeon
|
2018-06-20 17:13
라인
Companies enter pharma biz through equity investment, acquisition
More Korean companies are entering the pharmaceutical market either by equi...
by So Jae-hyeon
|
2018-06-18 16:13
라인
Samsung Bioepis to promote rheumatism treatments in Europe
Samsung Biopepis is stepping up efforts to enlarge its share in the Europea...
by So Jae-hyeon
|
2018-06-14 14:59
라인
What if South Korea supplies vaccines for North?
Under the reconciliatory atmosphere between South Korea and North Korea, a ...
by So Jae-hyeon
|
2018-06-12 15:36
라인
Obesity drugs marked poor sales in Q1
Most obesity treatments suffered sales declines in the first quarter, and p...
by So Jae-hyeon
|
2018-06-12 15:32
라인
60 general hospitals use genetic therapy Invossa
Kolon Life Science and Mundipharma Korea said Invossa-K, a knee osteoarthri...
by So Jae-hyeon
|
2018-06-11 15:12
라인
Multinationals dominated drug sales in Q1 -- again
Multinational pharmaceutical firms led local drug sales in the first quarte...
by So Jae-hyeon
|
2018-06-08 16:22
라인
Viagra, Cialis overcome by generic copies
Original drugs in the erectile dysfunction treatment market, such as Viagra...
by So Jae-hyeon
|
2018-06-05 10:55
라인
US law expected to benefit Korean drugmakers
Korean developers of anticancer treatments and orphan drugs have welcomed a...
by So Jae-hyeon
|
2018-06-04 16:02
라인
Eisai picks Chong Kun Dang as dementia drug sales partner
Eisai Korea, the Korean unit of the Japanese pharmaceutical company, has ch...
by So Jae-hyeon
|
2018-06-04 14:10
라인
Biosimilars quickly catch up with originals in Korea
Korean biosimilar drugs are quickly chasing original medicines in the domes...
by So Jae-hyeon
|
2018-06-01 15:37
라인
Pfizer Korea ignores reporters’ questions
“I do not think the questions are relevant to this occasion. Please check t...
by So Jae-hyeon
|
2018-06-01 15:18
라인
Korea United Pharm wages war on Chinese fake capsules
Korea United Pharm said it would seek compensation for damages against a Ch...
by So Jae-hyeon
|
2018-06-01 12:05
라인
OCI enters pharma sector via joint venture with Bukwang
Chemicals and energy firm OCI has announced that it would enter the pharmac...
by So Jae-hyeon
|
2018-05-31 15:38
라인
Procedures of genetic therapy Invossa exceed 1,000 cases
Kolon Life Science and Mundipharma Korea said on Wednesday that the number ...
by So Jae-hyeon
|
2018-05-31 14:14
라인
Korean biosimilar makers tap into Japan
Korean manufacturers of biosimilar products are making a foray into Japan, ...
by So Jae-hyeon
|
2018-05-30 15:41
라인
Will biotech stocks rebound on listings in H2?
The biotech industry is paying attention to whether upcoming initial public...
by So Jae-hyeon
|
2018-05-30 11:33
-
1
2
3
4
5
6
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top